Africa: Twice-Yearly Injectable Lenacapavir Treatment Shows 100pc Efficacy in HIV Prevention.

Africa has seen promising results in HIV prevention with the use of twice-yearly injectable lenacapavir treatment, showing 100% efficacy. This breakthrough treatment offers hope for reducing the spread of HIV in the region, marking a significant advancement in combating the disease. The study highlights the potential impact of this innovative approach on public health initiatives in Africa.

Source link